Limited Funding For Cures Acceleration Network Has Upside: Partnership Options
Congressional appropriations provide $10 million for the new program to speed development of therapies for “high need” diseases and conditions, substantially less than the $100 million requested by NIH.
You may also be interested in...
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.
Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.